Caitong International Asset Management Co. Ltd Has $32,000 Stake in Revvity Inc. $RVTY

Caitong International Asset Management Co. Ltd decreased its holdings in shares of Revvity Inc. (NYSE:RVTY) by 53.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 326 shares of the company’s stock after selling 368 shares during the quarter. Caitong International Asset Management Co. Ltd’s holdings in Revvity were worth $32,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. T. Rowe Price Investment Management Inc. grew its holdings in Revvity by 8.5% during the first quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company’s stock valued at $2,382,163,000 after purchasing an additional 1,754,403 shares during the period. Vanguard Group Inc. grew its holdings in Revvity by 0.6% during the first quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company’s stock valued at $1,521,705,000 after purchasing an additional 92,638 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in Revvity by 25.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company’s stock valued at $1,011,863,000 after purchasing an additional 1,932,314 shares during the period. EdgePoint Investment Group Inc. grew its holdings in Revvity by 32.1% during the first quarter. EdgePoint Investment Group Inc. now owns 5,360,847 shares of the company’s stock valued at $567,178,000 after purchasing an additional 1,302,616 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Revvity by 1.8% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,444,645 shares of the company’s stock valued at $364,443,000 after purchasing an additional 62,307 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Stock Performance

Shares of RVTY stock opened at $98.91 on Monday. The company’s fifty day simple moving average is $89.38 and its 200-day simple moving average is $92.37. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. The firm has a market cap of $11.48 billion, a PE ratio of 41.91, a P/E/G ratio of 3.30 and a beta of 0.98. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $129.50.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. The business had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.22 earnings per share. Equities research analysts expect that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Stockholders of record on Friday, January 16th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, January 16th. Revvity’s payout ratio is currently 11.86%.

Wall Street Analysts Forecast Growth

RVTY has been the subject of a number of analyst reports. Barclays decreased their price objective on shares of Revvity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Thursday, October 2nd. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Weiss Ratings reiterated a “sell (d+)” rating on shares of Revvity in a report on Saturday. Stifel Nicolaus dropped their price objective on shares of Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a report on Tuesday, July 29th. Finally, Evercore ISI cut their price objective on shares of Revvity from $108.00 to $106.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 7th. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $116.38.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.